Multicenter phase II study of moderate low-dose radiotherapy in indolent non-Hodgkin lymphoma: CLCG-iNHL-01 protocol.
Gao LR, Wang X, Xia C, Song YW, Wang L, Li X, Yang Y, Cao JZ, Chen K, Zhong QZ, Gao Y, Zhou SY, Feng XL, Wang X, Li YX, Qi SN.
Gao LR, et al. Among authors: yang y.
Future Oncol. 2024 Jan;20(2):71-81. doi: 10.2217/fon-2023-0761. Epub 2024 Jan 5.
Future Oncol. 2024.
PMID: 38179936